Aardvark Therapeutics (AARD) Return on Assets Growth (1y) (2026)
Aardvark Therapeutics (AARD) Return on Assets Growth (1y) (2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,402.79 Bn | 67,402.51 Bn | - |
| 2 | Nanobiotix | 1,930.72 Bn | 1,930.66 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 471.98 Bn | 467.19 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.50 Bn | 116.25 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.37 Bn | 61.61 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.41 Bn | 62.41 Bn | - |
| 8 | Argenx Se | 56.13 Bn | 50.94 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.51 Bn | 37.51 Bn | - |
| 10 | Aardvark Therapeutics | 143.77 Mn | 23.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |